SEIRE WP FAST PRIMER comp A

Hazard statements (CLP)

H315, H317, H319, H412

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause an allergic skin reaction 12/14/2020 (Revision date)

Hazard pictograms

GHS07

Signal word

Warning

Contains

2,2-bis-[4-(2,3-epoxypropoxy)phenyl]propane, polymer The following percentage of the mixture consists of ingredient(s) with unknown acute toxicity: 4.9995 %.

Hazard statements

H317 - May cause an allergic skin reaction.

Precautionary statements

P261 - Avoid breathing dust, fume, gas, mist, spray, vapours. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component 2,2-bis-[4-(2,3-epoxypropoxy)phenyl]propane, This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII polymer (25085-99-8) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component 2,2-bis-[4(2,3-epoxypropoxy)phenyl]propane (1675- The substance is not included in the list established in accordance with Article 59(1) of 54-3) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Hazardous to the aquatic environment – Chronic Hazard, Category 3 H412 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction. 12/14/2020 (Revision date)